Half Hero 2 Image

Research Updates

Our Impact

Cycle for Survival is determined to beat rare cancers. Participants and donors fund innovative research to discover new and better treatments options that will help people around the world.

This movement is driven by an exceptional community of patients, survivors, doctors, researchers, caregivers, and supporters. Together they have raised more than $50 million for rare cancer research in just eight years.100 percent of the donations have advanced more than 100 clinical trials, studies, and major research initiatives. Every dollar represents hope, strength, and a lasting impact.

Cycle for Survival Funds Progress

The work supported by Cycle for Survival has led to important discoveries. Many doctors and
scientists on the front lines in the battle against rare cancers couldn’t have pursued
innovative ideas without Cycle for Survival funding. Learn about some of the incredible progress
made: Read the featured research updates on this page. And check back throughout the year for
new information on Cycle for Survival-funded breakthroughs.

“Children with brain cancers urgently need better and safer treatment options and more effective ways to deliver the therapy. Cycle for Survival funding has been critical in advancing the research and clinical trials that
will help pediatric patients.”
Ira J. Dunkel, MD
Department of Pediatrics
“Funding from Cycle for Survival enables me and my colleagues to pursue exciting new ways to treat ovarian cancer, and to prevent the disease from recurring.
Thank you to the Cycle for Survival community
for supporting vital research.”
Roisin E. O'Cearbhaill, MD
Gynecologic Medical Oncology Service

News and Publications

Read more about Cycle for Survival’s impact on the cancer community worldwide.

Johanna Joyce,
Cancer Warrior

"Don't let Johanna Joyce's polite, soft-spoken demeanor fool you. The cancer biologist loves a good argument, a trait she credits to her Irish upbringing..."

View Article
Molecular Studies Provide
New Clues about Rare
Soft Tissue Sarcoma

A recent Memorial Sloan Kettering study suggests new ways to control malignant peripheral nerve sheath tumors (MPNSTs), a rare, aggressive type of soft tissue sarcoma.

View Article
Finding Clues in Genes of ‘Exceptional Responders’

"The annals of medicine are full of stories of exceptional responders, but until recently, they were just that: stories. Case histories that could not be generalized because there was no way to know why…"

View Article
Download more information

2014 Funding Allocation PDF


2013 Funding
Allocation PDF